This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Is Premier (PINC) a Great Stock for Value Investors?
by Nabaparna Bhattacharya
Let's see if Premier, Inc. (PINC) stock is a good choice for value-oriented investors right now from multiple angles.
New Strong Buy Stocks for February 13th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Why Earnings Season Could Be Great for Premier (PINC)
by Zacks Equity Research
Premier (PINC) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Masimo (MASI) Receives FDA Approval for SedLine, Shares Up
by Zacks Equity Research
Masimo (MASI) to overhaul neurological diagnoses with its next generation SedLine brain function monitoring.
New Strong Buy Stocks for January 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Is Premier (PINC) a Great Stock for Value Investors?
by Zacks Equity Research
Premier is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Premier, Penumbra, DigitalGlobe and Sunrun
by Zacks Equity Research
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Premier, Penumbra, DigitalGlobe and Sunrun
The Zacks Analyst Blog Highlights: Spark Energy, Investar Holding, CoreCivic, Premier and Taylor Morrison Home
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Spark Energy, Investar Holding, CoreCivic, Premier and Taylor Morrison Home
Zacks.com featured highlights: Coherent, Premier, Teck Resources, Leucadia National and Seagate Technology
by Zacks Equity Research
Zacks.com featured highlights: Coherent, Premier, Teck Resources, Leucadia National and Seagate Technology
Falling Earnings Estimates Signal Weakness Ahead for PAREXEL (PRXL)
by Zacks Equity Research
PAREXEL (PRXL) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.